Risk Intelligence
79 / 100
Fundamentally Qualified
How strong and defensively sound is the company?
Above average on this measure.
IDXX · NASDAQ
Sector unavailable · Industry unavailable
$504.70
-0.36%
Close on Sep 11, 2026
Updated 6/30/2026
Long-term research evidence only. No price targets, no trading signals, no recommendations.
Investment Report Card
Sector unavailable · Data confidence good
80 / 100
Rank #29 of 1,152 qualified companies
Top 5% · Worth a Closer Look
79 / 100
Fundamentally Qualified
How strong and defensively sound is the company?
Above average on this measure.
77 / 100
Weak Compounder
Does the business have the characteristics needed to create value over many years?
Above average on this measure.
72 / 100
Middle
Is the underlying business getting stronger or weaker?
Above average on this measure.
68 / 100
Positive disclosed activity
What are important owners actually doing?
Around the middle of the covered universe.
65 / 100
Attractive
Is today's price reasonable?
Around the middle of the covered universe — and valuation is researched separately from the Suggested Investment Score.
60 / 100
Favorable Capital Returns
How effectively does the company reward shareholders?
Around the middle of the covered universe — and capital returns are researched separately from the Suggested Investment Score.
No weakening evidence is recorded in today's readings.
IDEXX LABORATORIES INC scores 77 on Long-Term Potential (B), described by the research model as weak compounder. This describes business characteristics only — it is not a forecast of future returns.
Disclosed ownership evidence reads 68 (C+): Positive disclosed activity. 5 tracked managers disclosed a position in the latest reporting period. Ownership filings are historical disclosures, not signals.
IDEXX LABORATORIES INC reads 65 out of 100 on Valuation Intelligence, recorded as Attractive. The stock currently trades below most of its own recent valuation history and above comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value. Valuation Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.
IDEXX LABORATORIES INC reads 60 out of 100 on Capital Returns Intelligence (Favorable Capital Returns), reflecting a share count falling about 1.8% a year. Direct capital returns are limited because the company continues reinvesting most of its cash. Capital Returns Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.
No meaningful recorded changes in the stored history.
Risk Intelligence is a core model, Long-Term Potential, Fundamental Momentum, Valuation Intelligence and Capital Returns Intelligence are research models, and Ownership Intelligence is supplemental descriptive evidence. Valuation Intelligence and Capital Returns Intelligence each contribute 0% to the Suggested Investment Score. Nothing here is a recommendation.
Compare IDXX with other companiesAppears in
Membership means the company satisfied a published rule on the latest research build. It is not a recommendation.
About a minute to read
Written from stored research readings only. No hype. No trading signals. Just better evidence.
IDEXX LABORATORIES INC (IDXX) scores 80 out of 100 and ranks #29 of 1,152 qualified companies today. That places it in the top 5% of ranked companies. The stored tier for that score is worth a closer look.
Risk Intelligence reads 79 out of 100 (B), recorded as fundamentally qualified. Above average on this measure.
Long-Term Potential reads 77 out of 100 (B), recorded as weak compounder. Above average on this measure.
Fundamental Momentum reads 72 out of 100 (B−), recorded as middle. Above average on this measure.
Ownership Intelligence reads 68 out of 100 (C+), recorded as positive disclosed activity. Around the middle of the covered universe.
Valuation currently appears favourable: Valuation Intelligence reads 65 out of 100 (C), recorded as Attractive. IDEXX LABORATORIES INC reads 65 out of 100 on Valuation Intelligence, recorded as Attractive. The stock currently trades below most of its own recent valuation history and above comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value. Valuation Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.
Capital Returns Intelligence reads 60 out of 100 (C), recorded as Favorable Capital Returns. IDEXX LABORATORIES INC reads 60 out of 100 on Capital Returns Intelligence (Favorable Capital Returns), reflecting a share count falling about 1.8% a year. Direct capital returns are limited because the company continues reinvesting most of its cash. Capital Returns Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.
No weakening factors are recorded in today's stored readings, and data confidence is good. Absence of a recorded weakness is not evidence of safety.
No individual layer reaches the strongest band today. Separately from the score, valuation reads attractive at today's price.
Composite discovery model
Suggested Investment Score
80 / 100
A 0–100 composite discovery score combining Risk Intelligence, Long-Term Potential, Fundamental Momentum, and Ownership Intelligence. It helps rank qualified companies for further research and does not predict future returns.
30% contribution
30% contribution
20% contribution
20% contribution
68 / 100 · Positive · 20% of the Suggested Investment Score
Coverage: Good
50% of Ownership Intelligence · 10% of the total score
Tracked professional-manager activity is moderately positive.
20% of Ownership Intelligence · 4% of the total score
Broad institutional evidence from resolved filings is strong.
15% of Ownership Intelligence · 3% of the total score
No discretionary insider transactions are stored for this company, so this evidence is unavailable rather than neutral.
15% of Ownership Intelligence · 3% of the total score
No qualifying major-holder filings are stored, so this evidence is unavailable rather than neutral.
Ownership Intelligence summarizes publicly disclosed activity among professional investment managers, broader institutions, company insiders, and significant strategic owners. It adds context to investment research but is not a validated predictor of future performance. Ownership information is publicly reported with a delay; the latest applicable reporting period is 2026-06-30, publicly disclosed 9/11/2026. Congressional activity is unavailable pending legal review and contributes nothing to this reading.
Strong risk profile
Risk Intelligence ranks in the top 11% of qualified companies, with lower_risk price risk.
Exceptional long-term potential
Stored profitability, capital efficiency and reinvestment readings rank near the top of the qualified universe.
Improving fundamentals
Recent reported business trends rank among the strongest in the qualified universe.
Ownership evidence is not uniformly supportive
The combined disclosed ownership evidence ranks below the qualified median.
Ownership evidence disagrees
Different owner groups point in different directions, so the combined reading is best read as mixed rather than uniformly favourable.
COMPOSITE DISCOVERY MODEL — RESEARCH STAGE · Data coverage Excellent. Rankings are recalculated daily using the latest available information. Individual components may update at different frequencies based on when new financial and ownership data becomes available.
Researched separately
Valuation Intelligence 65 · Attractive
Valuation Intelligence is currently researched separately and does not affect the Suggested Investment Score or daily ranking.
Researched separately
Capital Returns Intelligence 60 · Favorable Capital Returns
Capital Returns Intelligence is researched separately and contributes 0% to the Suggested Investment Score, the daily rank or any ranking event.
Score explanation
Four research areas carry fixed weights. Each area is compared against every other eligible company, then weighted. The four contributions below add to 79.9 of the stored score (79.9).
Risk Intelligence
30% of the score · contributes 26.9 points
How strong and defensively sound is the company?
Stands at the 90 percentile of eligible companies · stored reading 79 · 34% of this company’s total score
How financially sturdy the company has been when conditions turned against it.
Risk Intelligence reads stored balance-sheet strength, historical downside behaviour and the company's price-risk grouping. A stronger reading describes past resilience; it does not protect against future losses.
Full methodologyLong-Term Potential
30% of the score · contributes 28.9 points
Does the business have the characteristics needed to create value over many years?
Stands at the 96 percentile of eligible companies · stored reading 77 · 36% of this company’s total score
Whether the business has the durable characteristics long-term owners look for.
Long-Term Potential reads durability characteristics such as profitability consistency, cash generation and reinvestment capability over multiple reported periods.
Full methodologyFundamental Momentum
20% of the score · contributes 17.4 points
Is the underlying business getting stronger or weaker?
Stands at the 87 percentile of eligible companies · stored reading 72 · 22% of this company’s total score
Whether the reported business results have been getting stronger or weaker.
Fundamental Momentum compares recent reported fundamentals with the company's own earlier periods, so improvement or deterioration is measured against its history rather than against a forecast.
Full methodologyOwnership Intelligence
20% of the score · contributes 6.7 points
What are important owners actually doing?
Stands at the 34 percentile of eligible companies · stored reading 68 · 8% of this company’s total score
What large reporting owners have actually been doing with their positions.
Ownership Intelligence reads public ownership filings: how many tracked reporting owners hold the company, and whether they were adding, holding, reducing or exiting in the latest disclosed period.
Full methodologyAdditional research — not currently included in the primary Suggested Investment Score.
Stored snapshots only
Research-score history available since September 2026.
Stored research history does not yet cover a full 30 days comparison for this company.
A change is reported as meaningful at 8 score points, 5 rank places, or any change of research classification. Nothing here is a recommendation to buy or sell.
Plain-English definitions, with the formula and the limitations of each measure.
Fifth research lens · outside the score
Valuation Intelligence
Valuation Intelligence is currently researched separately and does not affect the Suggested Investment Score or daily ranking.
Attractive
92
Very Attractive
Is this company expensive or inexpensive compared with its own history?
35
Elevated
How expensive is this stock compared with similar companies?
45
Elevated
How much financial output does an investor receive relative to the price paid?
84
Very Attractive
Does the company's growth help justify the valuation investors are paying?
IDEXX LABORATORIES INC reads 65 out of 100 on Valuation Intelligence, recorded as Attractive. The stock currently trades below most of its own recent valuation history and above comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value.
Price data through September 11, 2026 · Financial data through the quarter ended June 30, 2026
Stored readings only. The dashed line is this company's own median for the selected measure.
Only one stored valuation reading exists so far, so there is nothing to chart yet. Valuation history builds forward from activation rather than being reconstructed.
Current P/E 34.9x · own median 55.5x · peer median 32.4x
Valuation is inherently uncertain. A stock that appears inexpensive can continue falling, and a stock that appears expensive can continue rising. Valuation Intelligence provides context about the price investors are paying — it does not predict short-term market movements, and it never produces a fair value, a price target or a buy or sell range. Model VALUATION_INTELLIGENCE_V1.
Sixth research lens · outside the score
Capital Returns Intelligence
Capital Returns Intelligence is researched separately and contributes 0% to the Suggested Investment Score, the daily rank or any ranking event.
Favorable Capital Returns
—
Not Applicable — No Dividend
Dividend reliability
This company currently retains rather than distributes cash through dividends. Capital Returns Intelligence therefore places more emphasis on its other measurable shareholder-return behaviors according to the frozen V1 methodology.
71
Strong Capital Returns
Do buybacks actually reduce shares?
66
Favorable Capital Returns
Is your ownership share protected?
48
Moderate Capital Returns
Can the cash flow support it?
48
Moderate Capital Returns
Cash returned versus company value
IDEXX LABORATORIES INC reads 60 out of 100 on Capital Returns Intelligence (Favorable Capital Returns), reflecting a share count falling about 1.8% a year. Direct capital returns are limited because the company continues reinvesting most of its cash.
This company currently retains rather than distributes cash through dividends. Capital Returns Intelligence therefore places more emphasis on its other measurable shareholder-return behaviors according to the frozen V1 methodology.
How returned cash was used
Dividends $0.00 · net repurchases $1.06B · total returned $1.06B · 85% of free cash flow
Price data through September 11, 2026 · Financial data through the quarter ended June 30, 2026
Stored readings only. History builds forward from activation rather than being reconstructed.
Only one stored reading exists for this measure so far, so there is nothing to chart yet.
A very high dividend yield may reflect a falling share price or an unsustainable payout. Capital Returns Intelligence emphasizes consistency and sustainability rather than simply rewarding the highest yield.
Announced or gross buyback spending does not always mean shareholders are gaining ownership. Companies can simultaneously issue shares through employee compensation or acquisitions. Suggested Investments therefore considers actual share-count changes alongside repurchase spending.
Capital Returns Intelligence describes how a company returns capital to shareholders. It is not a measure of stock-price performance, it does not predict future returns, and a strong reading is never a recommendation to buy. Dividends and repurchases can be reduced or stopped at any time. Model CAPITAL_RETURNS_INTELLIGENCE_V1, contributing 0% to the Suggested Investment Score.
Stored daily snapshots only
| Today | #29 | Score 80 |
|---|---|---|
| 30 days ago | Not ranked | No stored score |
| 90 days ago | Not ranked | No stored score |
| First suggested | September 12, 2026 | |
| Highest rank | #29 | |
In the company’s own words
, Marketing and Distribution" included in this Annual Report on Form 10-K for additional information regarding distribution channels.
Effects of Patent Expiration . Although certain patents and licenses of patents and technologies from third parties periodically expire, the expiration of these patents or licenses, individually or in the aggregate, is not expected to have a material effect on our financial position or future operations due to a range of factors as described in "Part I, Item 1. Intellectual Property, Including Patents and License."
Non-GAAP Financial Measures . The following revenue analysis and discussion includes organic revenue growth, and references in this analysis and discussion to "revenue," "revenues," or "revenue growth" apply equally to revenue growth reported in accordance with U.S. GAAP and to "organic revenue growth." Organic revenue growth is a non-GAAP financial measure and represents the percentage change in revenue during the current year, compared to the same period for the prior year, net of the effect of changes in foreign currency exchange rates, certain business acquisitions, and divestitures. Organic revenue growth should be considered in addition to, and not as a replacement for, or as a superior measure to, revenue growth reported in accordance with U.S. GAAP, and may not be comparable to similarly titled measures reported by other companies. Management believes that reporting organic revenue growth provides useful information to investors by facilitating easier comparisons of our revenue performance with prior and future periods and to the performance of our peers.
We exclude from organic revenue growth the effect of changes in foreign currency exchange rates because changes in foreign currency exchange rates are not under management’s control, are subject to volatility, and can obscure underlying business trends. We calculate the impact on revenue resulting from changes in foreign currency exchange rates by applying the difference between the weighted average exchange rates during the current period and the comparable prior year period to foreign currency denominated revenues for the prior year period.
Quoted from the business section of this company’s 10-K filed February 20, 2026. Read the filing
Four distinct intelligence areas
79
Fundamentally Qualified
-7.3 vs Jun 30, 2026
Business Quality qualification score from the locked IA Defensive Research Core. Price Risk stays a separate category and is never blended in.
As of Sep 11, 2026
77
Elite Compounder
+35.5 vs Jun 30, 2026
Durable business economics and reinvestment characteristics. Independent external validation is pending.
As of Sep 11, 2026
72
Accelerating
+16.3 vs Jun 30, 2026
Direction and breadth of change in underlying business fundamentals. Not a price-momentum signal.
As of Sep 11, 2026
60
Mid range
0 vs Jun 30, 2026
Only 5 tracked managers disclosed a position — treat as limited coverage.
As of Sep 11, 2026
Company intelligence
Each area is measured and reported separately. No combined score exists.
IDXX intelligence history from 2023-09-30 to 2026-09-11. Risk Intelligence 78.5 on 2026-09-11, down 7.3 from 85.8 on 2026-06-30. Long-Term Potential 76.7 on 2026-09-11, up 35.5 from 41.2 on 2026-06-30. Fundamental Momentum 72.3 on 2026-09-11, up 16.3 from 56 on 2026-06-30. Elite Investor Activity 60 on 2026-09-11, unchanged 0 from 60 on 2026-06-30. Each area is reported separately and is never combined into a single score.
Risk Intelligence 78.5 as of Sep 11, 2026 (-7.3 vs prior period) · Production core
Long-Term Potential 76.7 as of Sep 11, 2026 (+35.5 vs prior period) · Research model
Fundamental Momentum 72.3 as of Sep 11, 2026 (+16.3 vs prior period) · Research model
Elite Investor Activity 60 as of Sep 11, 2026 (0 vs prior period) · Supplemental
Share price
Closing prices adjusted for splits and dividends. Past prices do not indicate future results.
Last stored close $504.70 · -21.8% over the selected range · 52 sessions shown
Balanced evidence
Risk and uncertainty
Public filings · descriptive only
Reporting holders
13
New holders
10
Increasing
0
Reducing
2
Exiting
0
Coverage
Excellent
Positive disclosed activity · Report period 2022-12-31 · Public 12/19/2023
| Manager | Change | Portfolio weight | Rank | Disclosed |
|---|
Insufficient high-confidence manager coverage.
Objective stored changes
IA Defensive weakened
Business Quality qualification score moved from 85.8 to 82.7.
Price Risk category changed
Price Risk moved from Not Available to Normal risk.
IA Compounder strengthened
IA Compounder research score moved from 41.2 to 70.1.
Fundamental Momentum improved
Fundamental Momentum research score moved from 56.0 to 75.9.
IA Compounder softened
IA Compounder research score moved from 70.1 to 41.2.
Fundamental Momentum softened
Fundamental Momentum research score moved from 76.2 to 56.0.
Elite Investor Consensus strengthened
Disclosed agreement among tracked managers moved from 17 to 60 for the reporting period ending 2026-06-30.
Elite Investor Consensus weakened
Disclosed agreement among tracked managers moved from 50 to 17 for the reporting period ending 2026-03-31.
Tracked managers exited positions
2 tracked managers no longer disclosed a position for the reporting period ending 2026-03-31.
Tracked managers initiated positions
2 tracked managers first disclosed a position for the reporting period ending 2025-12-31.
No high-confidence public ownership events are available.
General research only. Not personalized advice. Public filings may be delayed, amended, incomplete, or reflect positions that have changed since the reporting date.